玻利维亚传统食品市场针对SARS-CoV-2的混合免疫、疫苗诱导免疫与自然免疫(2020-2022年):一项血清学调查的横断面分析
本研究在玻利维亚两个传统食品市场对213名商贩于2020至2022年间开展重复血清学调查。2020年11月该队列中105人(49.3%)参与接种前市政血清学调查,当时血清阳性率为45.7%(95%CI 36.3-55.4)。至2021年11月,全队列67.8%接种过一剂疫苗,血清阳性率达83.6%;有疫苗接种加既往感染证据者IgG水平高于未接种者。至2022年5月,多数参与者产生抗体,上述差异减弱。
要点
- 2020年11月接种前市政调查中,队列内105人(49.3%)的血清阳性率为45.7%(95%CI 36.3-55.4)。
- 至2021年11月,全队列67.8%接种过一剂疫苗,血清阳性率为83.6%。
- 有疫苗接种和既往感染证据者IgG水平高于未接种者,至2022年5月差异减弱。
核心结论
- 2020年末相当比例商贩对SARS-CoV-2易感,当时全国超额死亡率高。
- 分析提示在大流行高峰时,自然感染联合疫苗接种提供的保护性抗体水平优于单纯自然感染。
- 未来大流行规划需要及时开展针对性血清学调查,以了解大流行动态并支持及时干预。
- 与有组织社区的沟通可为大流行缓解策略(包括提高疫苗接种率)的有效性提供信息。
- 及时的定量IgG水平监测也可为免疫衰减提供信息。
研究设计与样本
- 在玻利维亚两个有目的选取的市场中,对商贩队列于2020至2022年间开展调查轮次,收集人口学、临床和血清学数据。
- 利用这些纵向数据分析已接种疫苗者(有或无既往感染)与未接种者之间的SARS-CoV-2抗刺突抗体水平。
- 采用线性回归评估抗体水平与疫苗接种状态、社会人口学和健康信息之间的关联。
- 共有213名市场商贩在2021年7月、2021年11月和2022年5月进行了重复血清学采样。
主要发现
- 2020年11月,该队列中105人(49.3%)参与了接种前市政血清学调查,当时血清阳性率为45.7%(95%CI 36.3-55.4)。
- 至2021年11月,全队列67.8%接种过一剂疫苗,血清阳性率为83.6%。
- 有疫苗接种和既往感染证据的血清阳性参与者,其IgG水平高于未接种者。
- 至2022年5月,多数参与者产生了针对SARS-CoV-2的抗体,上述差异减弱。
关键数值与推荐
- 2020年11月接种前市政血清学调查中,队列内105人(49.3%)的血清阳性率为45.7%(95%CI 36.3-55.4)。
- 至2021年11月,全队列67.8%接种过一剂疫苗,血清阳性率为83.6%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In low-and middle-income countries, market vendors played a crucial role in food security during the coronavirus pandemic. High numbers of contacts, combined with social, political and health system upheaval in Bolivia, meant they were highly exposed to SARS-CoV-2 infections. METHODS: Demographic, clinical and serological data were collected at survey rounds between 2020 and 2022 from a cohort of market vendors in two purposively selected markets where the community and researchers co-promoted health and safety. We used these longitudinal data to examine SARS-CoV-2 anti-spike antibody levels between those vaccinated with and without previous infection and those unvaccinated. The association between antibody levels, and vaccine status, socio-demographic and health information was assessed using linear regression. FINDINGS: A total of 213 market vendors had repeated serological sampling in July, and November 2021, and again in May 2022. In November 2020, 105 (49.3 %) of this cohort had participated in a pre-vaccination municipal serological survey. Seroprevalence then was 45·7 % (95 %CI 36·3-55·4). By November 2021, 67·8 % of the full cohort had one vaccination and seroprevalence was 83·6 %. We showed IgG levels in those seropositive were higher in participants with evidence of vaccination and prior infection compared to those unvaccinated. By May 2022, the majority of participants developed antibodies against SARS-CoV-2, and these differences were attenuated. INTERPRETATION: A substantial proportion of vendors were susceptible to SARS-CoV-2 in late 2020 when, nationally, excess mortality was high. Our analyses suggested a combination of natural infection and vaccination provided better protective antibody levels than natural infection alone at the peak of the pandemic. Future pandemic planning requires timely targeted serological surveys to understand pandemic dynamics and support prompt interventions. In addition, communication with organized communities can inform effectiveness of pandemic mitigation strategies including improved vaccination uptake. Timely quantitative IgG level monitoring can also inform waning immunity. FUNDING: This study was supported by the Medical Research Council and a National Institutes for Health and Care Research (NIHR) Global Effort on COVID-19 (GECO) Health Research award 2020 [MR/V028561/1].
引用
- Leyns C, McClenaghan E, Rodriguez P, et al. Hybrid, vaccine-induced and natural immunity against SARS-CoV-2 in traditional food markets in Bolivia (2020-2022): A cross-sectional analysis of a serological survey. Vaccine. 2025. PMID: 40222090. doi:10.1016/j.vaccine.2025.127104
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。